# AXA Alternative Investments

> AXA Alternative Investments is a VC fund backing Health Care and Biotechnology. See 6 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Total investments: 6
- Last investment: Nov 2025
- Lead investor: 33%
- Last updated: Aug 2026
- Website: https://alts.axa-im.com

AXA Alternative Investments is a VC fund focused on Health Care and Biotechnology. AXA IM Alts' strategies are based on strong convictions, with the goal of providing long-term value to customers, communities, and the world. AXA IM Alts is part of AXA Investment Managers.

## Contacts

5 contacts available for AXA Alternative Investments. Shizune tracks 1 team members at AXA Alternative Investments. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/axa-im-alts?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 50% |
| Biotechnology | 3 | 50% |
| Life Science | 2 | 33% |
| Environmental Consulting | 2 | 33% |
| Forestry | 1 | 17% |

14 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 50% |
| Series B | 1 | 17% |
| Series C | 1 | 17% |
| Funding Round | 1 | 17% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 3 | 50% |
| Kenya | 1 | 17% |
| Brazil | 1 | 17% |
| Switzerland | 1 | 17% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Adam Gibbon | Natural Capital Investment Lead | 1 | https://shizune.co/investors/profile/adam-gibbon-63dd |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Imbria Pharmaceuticals | Imbria Pharmaceuticals’ mission is to translate our understanding of cellular metabolism into innovative medicines that improve the lives of patients with limited or inadequate treatment options. The company was founded by doctors and launched by an all doctor executive team motivated by the promise of bringing new therapies to people in need. Weare propelled by a deep scientific interest in cellular metabolism and the mitochondria, and are guided by both values and a code of business conduct built upon our commitment to always put the patients, families and communities we serve at the forefront of all that we do. |  | Series B | Nov 17, 2025 |  |
| Chloris Geospatial | Chloris Geospatial is able to provide answers today to critical natural capital issues. Chloris Geospatial provides innovative measurements of natural capital that use cutting-edge remote sensing, machine learning, and ecological science. | $14.8M | Series A | Jun 30, 2025 |  |
| ReproNovo | ReproNovo is providing patients all over the world with significant improvement by developing cutting-edge therapeutic solutions for uterine disorders including adenomyosis and for male and female infertility. | $65M | Series A | May 21, 2025 |  |
| Mombak | Mombak is a carbon removal company that focuses on the reforestation of the Amazon. The company's team combines experts in science, technology, forestry, and carbon markets | $30M | Series A | Apr 29, 2025 |  |
| Biolinq | Biolinq is a digital health platform developer that aims to create a pipeline of biomonitoring solutions. The company's platform includes a skin-applied, minimally invasive electrochemical biosensor that analyzes biomarkers in the interstitial fluid to provide actionable health information while continuously monitoring multiple biomarkers,allowing diabetic patients to monitor their blood glucose levels. | $100M | Series C | Mar 19, 2025 |  |
| Sistema.bio | Sistema.bio is a hybrid reactor biodigester that transforms the manure of animals into biogas and a potent, natural fertilizer. By inputting the manure in the system on a daily basis, you will be able to develop and grow your activities on the farm, improve your energy security, and protect the environment. Transforming your animals’ manure intoresource will provide you with a better quality of life! | $15M |  | Oct 14, 2024 |  |

6 of 6 investments shown.

## Co-investors
- [M Ventures](https://shizune.co/investors/profile/merckventures) — VC Fund, 2 deals together
- [Alpha Wave Ventures](https://shizune.co/investors/profile/alpha-wave-ventures) — VC Fund, 1 deal together
- [ALSA Ventures](https://shizune.co/investors/profile/alsa-ventures) — VC Fund, 1 deal together
- [AN Ventures](https://shizune.co/investors/profile/an-ventures) — VC Fund, 1 deal together
- [Aphelion Capital](https://shizune.co/investors/profile/aphelion-capital) — VC Fund, 1 deal together
- [At One Ventures](https://shizune.co/investors/profile/at-one-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Breakthrough Energy Ventures](https://shizune.co/investors/profile/breakthrough-energy-ventures) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [DOMO.VC](https://shizune.co/investors/profile/domo-invest) — VC Fund
- [Canary](https://shizune.co/investors/profile/canary-5) — VC Fund

## Featured in investor lists
- [Energy VC Funds in Brazil](https://shizune.co/investors/energy-vc-funds-brazil)
- [Life Science Investors in Switzerland](https://shizune.co/investors/life-science-investors-switzerland)

## FAQ

### What does AXA Alternative Investments invest in?

AXA Alternative Investments invests primarily in Health Care, Biotechnology and Life Science startups, most often at Series A and Series B stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact AXA Alternative Investments?

Public channels for AXA Alternative Investments include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at AXA Alternative Investments?

The team at AXA Alternative Investments includes Adam Gibbon (Natural Capital Investment Lead). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co